Literature DB >> 29405714

Metabolomics-Guided Discovery of Microginin Peptides from Cultures of the Cyanobacterium Microcystis aeruginosa.

Allison K Stewart1, Rudravajhala Ravindra1, Ryan M Van Wagoner1, Jeffrey L C Wright1.   

Abstract

We report a mass-spectrometry-based metabolomics study of a laboratory-cultured strain of Microcystis aeruginosa (UTEX LB2385), which has led to the discovery of five peptides (1-5) belonging to the microginin class of linear cyanopeptides. The structures and configurations of these peptides were determined by spectroscopic analyses and chemical derivitization. The microginin peptides described herein are the first reported derivatives containing N-methyl methionine (1, 5) and N-methyl methionine sulfoxide (2-4). The two tripeptide microginin analogues (4, 5) identified represent the smallest members of this peptide family. Their angiotensin-converting enzyme (ACE) inhibitory activity was also investigated. Microginin 527 (4) was the most potent of the group, with an IC50 of 31 μM.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29405714     DOI: 10.1021/acs.jnatprod.7b00829

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  2 in total

1.  Metabolome Variation between Strains of Microcystis aeruginosa by Untargeted Mass Spectrometry.

Authors:  Marianne Racine; Ammar Saleem; Frances R Pick
Journal:  Toxins (Basel)       Date:  2019-12-11       Impact factor: 4.546

2.  Metabolomics Tools Assisting Classic Screening Methods in Discovering New Antibiotics from Mangrove Actinomycetia in Leizhou Peninsula.

Authors:  Qin-Pei Lu; Yong-Mei Huang; Shao-Wei Liu; Gang Wu; Qin Yang; Li-Fang Liu; Hai-Tao Zhang; Yi Qi; Ting Wang; Zhong-Ke Jiang; Jun-Jie Li; Hao Cai; Xiu-Jun Liu; Hui Luo; Cheng-Hang Sun
Journal:  Mar Drugs       Date:  2021-12-01       Impact factor: 5.118

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.